ClinicalTrials.gg
CompletedNCT07632547Updated Sep 1, 2026

Video-Enhanced Tell-Show-Do for Managing Dental Anxiety in Children

An interventional study of Behavioral Treatment and Behavioral Treatment in Distraction and Behavior Management, sponsored by Damascus University. Completed at 1 site in Syria. Open to participants aged 4 Years to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-01.

Sponsored by Damascus University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
4 Years to 6 Years
Sex
All
01

Study summary

This study is the first of its kind to examine the effect of integrating the real oral environment with a video that supports the expressions used during the Tell-Show-Do technique (such as "we will see the cavity," "the cavity will drink juice to fall asleep," and "we will clean the tooth from the cavity"). This approach aims to enhance the Tell-Show-Do technique, build trust with the child, and reduce anxiety at the different stages of dental treatment in the clinical setting.

Read the detailed description

Dental fear and anxiety in children are associated with several visual stimuli, such as the shape of the dental handpiece or saliva ejector, as well as painful procedures like local anaesthesia, which may create a barrier to receiving dental treatment. Many studies have explored various behaviour management techniques to reduce anxiety during treatment; however, few have investigated the effect of using a video simulation of the real oral environment to familiarise children with treatment steps and reinforce the phrases commonly used by the dentist. This study was designed to reassure children by using a video that demonstrates carious lesions and dental instruments, including the mirror, saliva ejector, handpiece, and syringe, and shows how they work inside the mouth in a child-friendly manner.

This research is a randomised controlled clinical trial in which participants were assigned to two groups based on the behaviour management technique used. Anxiety was assessed using three integrated measures: a self-reported anxiety scale, an observer-rated behaviour scale, and physiological indicators including oxygen saturation and heart rate. All measures were recorded before, during, and after treatment to provide a comprehensive evaluation of the intervention's effect on children's anxiety levels.

02

Conditions studied

  • Distraction
  • Behavior Management

Browse trials for

Keywords

  • Dental anxiety
  • Video modeling / Simulation
  • Tell-Show-Do technique
03

In context

Behavior

1,573 studies on the registry are indexed under Behavior; 313 are open to participants now.

This study's enrollment of 80 is below the median of 120 across 1,197 interventional studies indexed under Behavior.

Browse Behavior studies →

Lead sponsor

Damascus University is the lead sponsor of 212 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Children aged 4-6 years, with or without previous dental experience.
  2. Children with a positive behavior rating according to the Frankl scale.
  3. Children with primary molars requiring conservative dental treatment.

Exclusion criteria

Exclusion Criteria:

  1. Children with systemic or mental disorders.
  2. Children who received sedative or analgesic medications within the 3 hours prior to the dental visit.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (actual)

Study arms

  • Active comparator
    Tell-Show-Do behavior management technique

    Children in this group will receive restorative treatment with following the traditional TSD technique without any visual aids.

    Behavioral: Behavioral Treatment

  • Experimental
    Real-Oral Simulation Video-Assisted Tell-Show-Do Technique

    Children in this group will receive restorative treatment with following the enhanced Tell-Show-Do technique with a video simulating the real oral environment

    Behavioral: Behavioral Treatment

Interventions

  • BehavioralBehavioral Treatment

    This group received treatment guided by the Tell-Show-Do (TSD) method. Each step was explained through simple analogies-referring to local anesthesia as 'sleepy juice' and the rubber dam as a 'trap' for the 'tooth worm.' After the explanation and instrument demonstration, restorative treatment was carried out. The protocol excluded the use of any audiovisual aids. All procedures involved conservative restoration of the mandibular primary molars

    Also known as: Tell-Show-Do Technique

  • BehavioralBehavioral Treatment

    Children in this group were managed using a video-assisted Tell-Show-Do (VATSD) approach incorporating real-oral simulation. Each procedural step was preceded by a specific segment of a pre-recorded video tailored to the upcoming task. The video featured a simulated intraoral environment where dental caries was personified by an animated 'tooth worm' to explain decay and its removal. Consistent with conventional TSD, the video integrated child-friendly analogies: local anesthesia was introduced as 'sleepy juice'-depicting the 'tooth worm' falling asleep-and the rubber dam was shown as a barrier to prevent its escape. These segments sequentially covered examination, anesthesia, rubber dam placement, and cavity preparation. Each viewing was followed by a standardized verbal explanation before performing the clinical procedure. All participants underwent conservative restorative treatment of the mandibular primary molars

    Also known as: Real-Oral Simulation Video-Assisted Tell-Show-Do Technique

06

What researchers measure

Primary outcomes

  1. Heart Rate

    Assessment tool: Pulse oximeter Measurement unit: Beats per minute (bpm) Assessment time points: Heart rate was assessed during a single dental treatment visit at baseline before treatment, after behavior management, during local anesthetic injection, before and during rubber dam placement, before handpiece use, and during restorative treatment.

    Time frame: during a single dental treatment visit at baseline before treatment, after behavior management, during local anesthetic injection, before and during rubber dam placement, before handpiece use, and during restorative treatment.

  2. Facial Image Scale (FIS)

    Assessment tool: Facial Image Scale questionnaire Measurement unit: Ordinal score (1-5) Assessment time points: Facial Image Scale was assessed during a single dental treatment visit at baseline and during treatment.

    Time frame: The Facial Image Scale was assessed during a single dental treatment visit at baseline (first visit before intervention) and during dental treatment.

Secondary outcomes

  1. Oxygen Saturation (SpO₂)

    Assessment tool: Pulse oximeter Measurement unit: Percentage (%) Assessment time points: Oxygen saturation was measured using a pulse oximeter and recorded during a single dental treatment visit at baseline, after behavior management, during local anesthetic injection, before and during rubber dam placement, before handpiece use, and during dental treatment.

    Time frame: Baseline; after behavior management; during injection; before rubber dam placement; during rubber dam placement; before handpiece use; during treatment during a single dental treatment visit.

07

Study locations

1 site
  • Damascus University
    Damascus, Syria
08

References and documents

Publications

  • Abbasi H, Saqib M, Jouhar R, Lal A, Ahmed N, Ahmed MA, Alam MK. The Efficacy of Little Lovely Dentist, Dental Song, and Tell-Show-Do Techniques in Alleviating Dental Anxiety in Paediatric Patients: A Clinical Trial. Biomed Res Int. 2021 May 23;2021:1119710. doi: 10.1155/2021/1119710. eCollection 2021. PubMed 34124238 ↗
  • Khandelwal D, Kalra N, Tyagi R, Khatri A, Gupta K. Control of Anxiety in Pediatric Patients using "Tell Show Do" Method and Audiovisual Distraction. J Contemp Dent Pract. 2018 Sep 1;19(9):1058-1064. PubMed 30287704 ↗
  • Seligman LD, Hovey JD, Chacon K, Ollendick TH. Dental anxiety: An understudied problem in youth. Clin Psychol Rev. 2017 Jul;55:25-40. doi: 10.1016/j.cpr.2017.04.004. Epub 2017 Apr 19. PubMed 28478271 ↗
  • Liu Y, Gu Z, Wang Y, Wu Q, Chen V, Xu X, Zhou X. Effect of audiovisual distraction on the management of dental anxiety in children: A systematic review. Int J Paediatr Dent. 2019 Jan;29(1):14-21. doi: 10.1111/ipd.12430. Epub 2018 Oct 26. PubMed 30362187 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2026 to primary completion in Jul 2026, 3 months.

Of 741 non-industry interventional studies with no phase under Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's 3 months is below that.

Counting every sponsor, half of 757 studies reached it within 13 months; a quarter within 5 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
May 7, 2026
First posted
Jun 8, 2026
StartActual
Apr 1, 2026
Primary completionActual
Jul 1, 2026
CompletionActual
Aug 1, 2026
Last update
Sep 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07632547
Responsible party
Sponsor
First posted
Jun 8, 2026
Start date
Apr 1, 2026
Primary completion
Jul 1, 2026
Completion
Aug 1, 2026
Last update
Sep 1, 2026

Study contacts

Chaza Kouchaji
study director · Damascus University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion